Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Clinical Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12538471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The multifunctional role of transforming growth factor (TGF)-ßs on mammary epithelial cell biology

  2005cited by this paper
• The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients

  2004cited by this paper
• Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines.

  2001cited by this paper
• Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung.

  2001cited by this paper
• Retroviral Overexpression of Decorin Differentially Affects the Response of Arterial Smooth Muscle Cells to Growth Factors

  2001cited by this paper
• Influence of decorin expression on transforming growth factor-beta-mediated collagen gel retraction and biglycan induction.

  2000cited by this paper
• Lumican and decorin are differentially expressed in human breast carcinoma

  2000influential reference
• Tissue structure, nuclear organization, and gene expression in normal and malignant breast.

  1999cited by this paper
• Fibromodulin-null Mice Have Abnormal Collagen Fibrils, Tissue Organization, and Altered Lumican Deposition in Tendon*

  1999cited by this paper
• The Biology of the Small Leucine-rich Proteoglycans

  1999cited by this paper
• Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis.

  1999cited by this paper
• Genetic events and the role of TGF beta in epithelial tumour progression.

  1999cited by this paper
• Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.

  1999cited by this paper
• Decorin Is a Biological Ligand for the Epidermal Growth Factor Receptor*

  1999cited by this paper
• Absence of integrin alpha1beta1 in the mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis.

  1999cited by this paper
• Identification of the woman at risk for breast cancer: problem solved?

  1999cited by this paper
• Genetic events and the role of TGFβ in epithelial tumour progression

  1999cited by this paper
• Expression of lumican in human breast carcinoma.

  1998cited by this paper
• Lumican Regulates Collagen Fibril Assembly: Skin Fragility and Corneal Opacity in the Absence of Lumican

  1998cited by this paper
• Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor.

  1998cited by this paper
• Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice

  1998cited by this paper
• Overexpression of EGFR and c‐erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts

  1998cited by this paper
• New targets, drugs, and approaches for the treatment of cancer: An overview

  1998cited by this paper
• Mice That Lack Thrombospondin 2 Display Connective Tissue Abnormalities That Are Associated with Disordered Collagen Fibrillogenesis, an Increased Vascular Density, and a Bleeding Diathesis

  1998cited by this paper
• Lysyl oxidase: properties, regulation and multiple functions in biology.

  1998cited by this paper
• Prevention of EGF‐modulated adhesion of tumor cells to matrix proteins by specific EGF receptor inhibition

  1998cited by this paper
• Transforming growth factor-beta in breast cancer: a working hypothesis.

  1997cited by this paper
• Transforming growth factor-β in breast cancer: A working hypothesis

  1997cited by this paper
• Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples.

  1997cited by this paper
• Direct binding and activation of receptor tyrosine kinases by collagen.

  1997cited by this paper
• Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases.

  1997cited by this paper
• The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth.

  1997cited by this paper
• Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility

  1997cited by this paper
• Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma.

  1997cited by this paper
• Decorin-induced Growth Suppression Is Associated with Up-regulation of p21, an Inhibitor of Cyclin-dependent Kinases*

  1996cited by this paper
• A prognostic index for ductal carcinoma in situ of the breast

  1996cited by this paper
• The NCIC-Manitoba Breast Tumor Bank: a resource for applied cancer research.

  1996cited by this paper
• De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells.

  1995cited by this paper
• The Human Lumican Gene

  1995cited by this paper
• Dynamic reciprocity revisited: a continuous, bidirectional flow of information between cells and the extracellular matrix regulates mammary epithelial cell function.

  1995cited by this paper
• Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue.

  1995cited by this paper
• Involvement of extracellular matrix constituents in breast cancer.

  1995cited by this paper
• Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

  1994influential reference
• Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction.

  1994cited by this paper
• Altered proteoglycan gene expression and the tumor stroma

  1993cited by this paper
• Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.

  1993cited by this paper
• Collagens and their abnormalities in a wide spectrum of diseases.

  1993cited by this paper
• Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: neu and tamoxifen failure.

  1990cited by this paper
• Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu.

  1989cited by this paper
• Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture.

  1984cited by this paper

• Systemic and local decorin levels mirror the clinical course of pancreatic cancer

  2025cites this paper
• Exploring New Frontiers: Alternative Breast Cancer Treatments Through Glycocalyx Research

  2025cites this paper
• Decorin Evokes a Pro‐Lysosomal Pathway in Lymphatic Endothelial Cells

  2025cites this paper
• A review on targeting tunable nanocarrier interaction, physiochemical properties, and futuristic nanocarrier.

  2025cites this paper
• Oncolytic adenovirus encoding decorin and CD40 ligand inhibits tumor growth and liver metastasis via immune activation in murine colorectal tumor model

  2024cites this paper
• Exploring the molecular mechanism of Solanum nigrum L in breast cancer treatment through network pharmacology and molecular docking validation

  2024cites this paper
• Extracellular Matrix Orchestration of Tissue Remodeling in the Chronically Inflamed Mouse Colon

  2024cites this paper
• Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression

  2024cites this paper
• Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan‐1 expression

  2024cites this paper
• The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis

  2023cites this paper
• Breast cancer patient-derived microtumors resemble tumor heterogeneity and enable protein-based stratification and functional validation of individualized drug treatment

  2023cites this paper
• All-in-One digital microfluidics pipeline for proteomic sample preparation and analysis

  2023cites this paper
• Monitoring of breast cancer progression via aptamer-based detection of circulating tumor cells in clinical blood samples

  2023cites this paper
• GALNT1 Expression Is Associated with Angiogenesis and Is a Prognostic Biomarker for Breast Cancer in Adolescents and Young Adults (AYA)

  2023cites this paper
• Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging

  2023cites this paper
• The upregulation of keratocan promotes the progression of human pancreatic cancer

  2023cites this paper
• The role of myokines in cancer: crosstalk between skeletal muscle and tumor

  2023cites this paper
• Enantioanalysis of Leucine in Whole Blood Samples Using Enantioselective, Stochastic Sensors

  2023cites this paper
• Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression

  2023cites this paper
• Molecular cues for immune cells from small leucine-rich repeat proteoglycans in their extracellular matrix-associated and free forms.

  2023cites this paper
• Global impact of proteoglycan science on human diseases

  2023cites this paper
• Integrative Analysis Constructs an Extracellular Matrix-Associated Gene Signature for the Prediction of Survival and Tumor Immunity in Lung Adenocarcinoma

  2022cites this paper
• The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of Lumican

  2022cites this paper
• The Role of Extracellular Matrix Proteins in Breast Cancer

  2022cites this paper
• Identification of significant genes associated with prognosis of gastric cancer by bioinformatics analysis

  2022cites this paper
• A Knowledge-Based Discovery Approach Couples Artificial Neural Networks With Weight Engineering to Uncover Immune-Related Processes Underpinning Clinical Traits of Breast Cancer

  2022cites this paper
• Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways.

  2022cites this paper
• Joint Secondary Transcriptomic Analysis of Non-Hodgkin’s B-Cell Lymphomas Predicts Reliance on Pathways Associated with the Extracellular Matrix and Robust Diagnostic Biomarkers

  2022cites this paper
• Decorin evokes reversible mitochondrial depolarization in carcinoma and vascular endothelial cells.

  2022cites this paper
• Proteomic Identification of a Gastric Tumor ECM Signature Associated With Cancer Progression

  2022cites this paper
• Down-Regulation of the Proteoglycan Decorin Fills in the Tumor-Promoting Phenotype of Ionizing Radiation-Induced Senescent Human Breast Stromal Fibroblasts

  2021cites this paper
• Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response

  2021cites this paper
• The Genes Encoding Small Leucine-Rich Proteoglycans Undergo Differential Expression Alterations in Colorectal Cancer, Depending on Tumor Location

  2021cites this paper
• Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients.

  2021cites this paper
• Stromal expression of cancer-associated fibroblast-related molecules, versican and lumican, is strongly associated with worse relapse-free and overall survival times in patients with esophageal squamous cell carcinoma

  2021cites this paper
• Differential MMP-14 Targeting by Lumican-Derived Peptides Unraveled by In Silico Approach

  2021cites this paper
• The matrix in cancer

  2021cites this paper
• CHPF promotes malignancy of breast cancer cells by modifying syndecan-4 and the tumor microenvironment.

  2021cites this paper
• Lumican inhibits immune escape and carcinogenic pathways in colorectal adenocarcinoma

  2021cites this paper
• Decorin in the Tumor Microenvironment.

  2020cites this paper
• Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma

  2020cites this paper
• Three-Dimensional Models as a New Frontier for Studying the Role of Proteoglycans in the Normal and Malignant Breast Microenvironment

  2020cites this paper
• Label-Free Infrared Spectral Histology of Skin Tissue Part II: Impact of a Lumican-Derived Peptide on Melanoma Growth

  2020cites this paper
• Biomarkers of tumor invasiveness in proteomics (Review)

  2020cites this paper
• Two Secreted Proteoglycans, Activators of Urothelial Cell–Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression

  2020cites this paper
• Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression

  2020cites this paper
• The Biology of Decorin in the Tumor Microenvironment

  2020cites this paper
• LUM is the hub gene of advanced fibrosis in nonalcoholic fatty liver disease patients.

  2020cites this paper
• Keratan Sulphate in the Tumour Environment.

  2020cites this paper
• While Urine and Plasma Decorin Remain Unchanged in Prostate Cancer, Prostatic Tissue Decorin Has a Prognostic Value.

  2020cites this paper
• The Tumor Microenvironment: Focus on Extracellular Matrix.

  2020cites this paper
• ArticleTwo Secreted Proteoglycans

  2020cites this paper
• Tissue engineering applications in breast cancer

  2020cites this paper
• Lumican, Pro-tumorigenic or Anti-tumorigenic: A Conundrum.

  2020cites this paper
• Multifaceted transforming growth factor-beta (TGFβ) signalling in glioblastoma.

  2020cites this paper
• Framing cancer progression: influence of the organ‐ and tumour‐specific matrisome

  2020cites this paper
• Epithelial-to-Mesenchymal Transition and invadopodia markers in breast cancer: Lumican a key regulator.

  2020cites this paper
• Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients' Outcome.

  2019cites this paper
• Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer

  2019cites this paper
• The extracellular matrix as a multitasking player in disease

  2019cites this paper
• Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer.

  2019cites this paper
• Oncolytic Adenovirus rAd.DCN Inhibits Breast Tumor Growth and Lung Metastasis in an Immune-Competent Orthotopic Xenograft Model

  2019cites this paper
• Semiparametric Bayesian kernel survival model for evaluating pathway effects

  2018cites this paper
• Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches

  2018influential citation
• Identification and characterization of biomarkers reflecting extracellular matrix remodeling in cancer

  2018cites this paper
• Semiparametric Bayesian Kernel Survival Model for Highly Correlated High-Dimensional Data.

  2018cites this paper
• Engineering Breast Cancer Microenvironments and 3D Bioprinting

  2018cites this paper
• Valor pronóstico del análisis de marcadores moleculares mediante proteómica dirigida en cáncer de mama precoz con receptores hormonales positivos

  2018cites this paper
• Quantitative mass spectrometry analysis reveals a panel of nine proteins as diagnostic markers for colon adenocarcinomas

  2018cites this paper
• Rolle von transmembranen Ektoenzymen wie Aminopeptidase N und Autotaxin beim Schilddrüsenkarzinom bezüglich ihres Einflusses auf Dedifferenzierung, Invasivität und Transformation

  2018cites this paper
• Lumican as a multivalent effector in wound healing

  2018cites this paper
• Proteoglycans—Biomarkers and Targets in Cancer Therapy

  2018cites this paper
• Anti-tumor responses to hypofractionated radiation in mice grafted with triple negative breast cancer is associated with decorin induction in peritumoral muscles

  2018cites this paper
• Small leucine-rich proteoglycans and matrix metalloproteinase-14: Key partners?

  2017cites this paper
• Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder

  2017cites this paper
• Functional proteomics outlines the complexity of breast cancer molecular subtypes

  2017cites this paper
• Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D‐LC‐MS/MS

  2017cites this paper
• Stromal Modulators of TGF-β in Cancer

  2017cites this paper
• Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition

  2017cites this paper
• An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation

  2017cites this paper
• Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide

  2017cites this paper
• Adenovirus-mediated decorin expression induces cancer cell death through activation of p53 and mitochondrial apoptosis

  2017cites this paper
• The extracellular matrix in cancer progression: Role of hyalectan proteoglycans and ADAMTS enzymes.

  2017cites this paper
• Role of the Extracellular Matrix in Tumor Stroma: Barrier or Support?

  2017cites this paper
• Extracellular Proteoglycan Decorin in Bovine Mammary Physiology

  2017cites this paper
• Human Metaplastic Breast Carcinoma and Decorin

  2017cites this paper
• Proteoglycans remodeling in cancer: Underlying molecular mechanisms.

  2017cites this paper
• Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line.

  2017cites this paper
• The method for breast cancer grade prediction and pathway analysis based on improved multiple kernel learning

  2017cites this paper
• Proteomic characterization of microdissected breast tissue environment provides a protein‐level overview of malignant transformation

  2017cites this paper
• The extracellular matrix in breast cancer.

  2016cites this paper
• Decorin as a multivalent therapeutic agent against cancer.

  2016cites this paper
• Changes in Expression of Genes Representing Key Biologic Processes after Neoadjuvant Chemotherapy in Breast Cancer, and Prognostic Implications in Residual Disease

  2016cites this paper
• Glycoprotein screening in colorectal cancer based on differentially expressed Tn antigen.

  2016cites this paper
• Matricellular proteins as regulators of cancer metastasis to bone.

  2016cites this paper
• Dissecting the Biology of Menstrual Cycle-Associated Breast Cancer Risk

  2016cites this paper
• Étude des conséquences de la déficience génétique en ß1,3-galactosyltransférase 6 (ß3GalT6) sur la pathogénie d’une maladie génétique rare, le syndrome d’Ehlers-Danlos (SED)

  2016cites this paper
• Traveling on discrete embeddings of gene expression

  2016cites this paper
• Reduced decorin expression in the tumor stroma correlates with tumor proliferation and predicts poor prognosis in patients with I–IIIA non-small cell lung cancer

  2016cites this paper
• The extracellular matrix in breast cancer predicts prognosis through composition, splicing, and crosslinking.

  2016cites this paper